STOCK TITAN

BioTech Medics-OTC CEO Interview and the Company Launches Its YouTube Channel

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

BioTech Medics, Inc. (OTC PINK:BMCS) has announced two significant developments. Firstly, the company's CEO, Anthony K. Miller, participated in an interview with The Beast of Wall Street on August 8, 2024, discussing the company's past, present, and future. Secondly, BioTech Medics has launched its official YouTube channel @Biotech Medics.

The YouTube channel will feature various content, including promotional videos and excerpts from the CEO's recent interview. Miller encourages viewers to subscribe and enable notifications to stay updated on the company's business and operations. He expressed hope that these press releases and videos will help investors understand BioTech Medics' business model, which he believes will be a long-running and profitable enterprise.

BioTech Medics, Inc. (OTC PINK:BMCS) ha annunciato due sviluppi significativi. In primo luogo, il CEO dell'azienda, Anthony K. Miller, ha partecipato a un'intervista con The Beast of Wall Street l'8 agosto 2024, discutendo del passato, presente e futuro dell'azienda. In secondo luogo, BioTech Medics ha lanciato il suo canale ufficiale di YouTube @Biotech Medics.

Il canale YouTube presenterà vari contenuti, tra cui video promozionali ed estratti dall'intervista recente del CEO. Miller incoraggia gli spettatori a iscriversi e attivare le notifiche per rimanere aggiornati sulle attività e operazioni dell'azienda. Ha espresso la speranza che questi comunicati stampa e video aiutino gli investitori a comprendere il modello di business di BioTech Medics, che crede sarà un imprenditore duraturo e redditizio.

BioTech Medics, Inc. (OTC PINK:BMCS) ha anunciado dos desarrollos significativos. En primer lugar, el CEO de la compañía, Anthony K. Miller, participó en una entrevista con The Beast of Wall Street el 8 de agosto de 2024, donde discutió sobre el pasado, presente y futuro de la empresa. En segundo lugar, BioTech Medics ha lanzado su canal oficial de YouTube @Biotech Medics.

El canal de YouTube presentará varios contenidos, incluidos videos promocionales y extractos de la reciente entrevista con el CEO. Miller anima a los espectadores a suscribirse y activar las notificaciones para mantenerse actualizados sobre los negocios y operaciones de la compañía. Expresó su esperanza de que estos comunicados de prensa y videos ayuden a los inversionistas a comprender el modelo de negocio de BioTech Medics, que él cree que será una empresa rentable y a largo plazo.

BioTech Medics, Inc. (OTC PINK:BMCS)는 두 가지 중요한 발전 사항을 발표했습니다. 첫째, 회사 CEO인 Anthony K. Miller가 2024년 8월 8일 The Beast of Wall Street와의 인터뷰에 참여하여 회사의 과거, 현재 및 미래에 대해 논의했습니다. 둘째, BioTech Medics는 공식 유튜브 채널 @Biotech Medics를 개설했습니다.

유튜브 채널은 홍보 비디오와 CEO의 최근 인터뷰 발췌를 포함한 다양한 콘텐츠를 제공할 예정입니다. 밀러는 시청자들이 구독하고 알림을 활성화하여 회사의 비즈니스 및 운영에 대한 업데이트를 받을 수 있도록 권장했습니다. 그는 이러한 보도 자료와 비디오가 투자자들이 BioTech Medics의 비즈니스 모델을 이해하는 데 도움이 될 것이라고 희망했으며, 이 모델이 지속적이고 수익성 있는 기업이 될 것이라고 믿고 있습니다.

BioTech Medics, Inc. (OTC PINK:BMCS) a annoncé deux développements significatifs. Premièrement, le PDG de l'entreprise, Anthony K. Miller, a participé à une interview avec The Beast of Wall Street le 8 août 2024, où il a discuté du passé, du présent et de l'avenir de l'entreprise. Deuxièmement, BioTech Medics a lancé son chaîne officielle YouTube @Biotech Medics.

La chaîne YouTube proposera divers contenus, notamment des vidéos promotionnelles et des extraits de l'interview récente du PDG. Miller encourage les téléspectateurs à s'abonner et à activer les notifications pour rester informés des activités et opérations de l'entreprise. Il a exprimé l'espoir que ces communiqués de presse et vidéos aideront les investisseurs à comprendre le modèle commercial de BioTech Medics, qu'il croit être une entreprise durable et rentable.

BioTech Medics, Inc. (OTC PINK:BMCS) hat zwei bedeutende Entwicklungen bekannt gegeben. Erstens nahm der CEO des Unternehmens, Anthony K. Miller, am 8. August 2024 an einem Interview mit The Beast of Wall Street teil, in dem er über die Vergangenheit, Gegenwart und Zukunft des Unternehmens sprach. Zweitens hat BioTech Medics seinen offiziellen YouTube-Kanal @Biotech Medics gestartet.

Der YouTube-Kanal wird verschiedene Inhalte präsentieren, darunter Werbevideos und Ausschnitte aus dem kürzlichen Interview mit dem CEO. Miller ermutigt die Zuschauer, den Kanal zu abonnieren und die Benachrichtigungen zu aktivieren, um über die Geschäfts- und Betriebsabläufe des Unternehmens auf dem Laufenden zu bleiben. Er äußerte die Hoffnung, dass diese Pressemitteilungen und Videos den Investoren helfen werden, das Geschäftsmodell von BioTech Medics zu verstehen, das seiner Meinung nach ein langfristiges und profitables Unternehmen sein wird.

Positive
  • Launch of official YouTube channel for improved investor communication
  • CEO's participation in an interview discussing company's past, present, and future
Negative
  • None.

WOODLAND HILLS, CA / ACCESSWIRE / August 12, 2024 / BioTech Medics, Inc. (OTC PINK:BMCS) is pleased to announce that the company's CEO sat down for an interview with The Beast of Wall Street on August 8, 2024 to discuss the past present and future of BioTech Medics, Inc. This interview can be found at the following link: https://x.com/dsalzarulo/status/1821592473652883916?s=46 additionally an excerpt of this interview can be found on the Company's YouTube Channel @Biotech Medics

According to Anthony K. Miller, CEO, "in preparing this press release there were three (3) issues that troubled me #1 the interview was over 1 hour long; #2 the audio quality was not great even with enhancements #3 nobody has that much time to listen to me ramble about our excellent business opportunity. So, Today I announce our YouTube channel @Biotech Medics and I hope that you listen to some of the videos that I just placed on this channel. They range from our promotional videos to me just recreating excerpts (and topics) from the August 8 interview. This will be a permanent place where we will continue to add content related to our business and operations. My hope is that you hit the Subscribe button and Notification Bell and you will get our videos directly when we upload them. My hope is that these series of press releases and now videos will help you understand our excellent business model that we feel will be a long running and profitable enterprise… commented Miller"

About BioTech Medics, Inc.: BioTech Medics, Inc. (website http://bmcs.company) is a publicly traded Wyoming company traded on the OTC Markets (under the stock symbol BMCS) located in the Los Angeles, California area. Management decided to take the Company back to its biotech roots and did initiate an agreement with certain asset holders in the Dominican Republic with Calcium carbonate reserves. On September 28, 2023 as a result of a negotiated agreement, BioTech Medics received 2 million metric tons of very high quality (99.8% pure) calcium carbonate to market to a worldwide marketplace. This calcium carbonate has a base value of $30 million dollars. Management did procure (along with this transaction) an option to acquire an additional 48 million metric tons of calcium carbonate at a similar transaction value. Our new business plan is an old school commodities plan where we mine our calcium, put in on a truck and then put it on a ship to send it to the client. This business model has traditional profit margins in excess of 33% per transaction. BMCS is not a Financial Services Company; and Management suggest that potential investors should not use the Companies digital assets, currently on our books. as a calculation to invest in BMCS.

Commodity Vault is a tokenization platform with the goal of creating new investment opportunities, while providing helpful capital options to mining and commodity driven companies. Our app turn real-world commodities like gold, gems, and metals into digital tokens, which can then be purchased, traded, or sold 24 hr/day in 173 countries. We provide the infrastructure to facilitate these transactions. We create significant opportunities for companies by establishing the capacity to use a fixed asset, converted into multiple digital tokens that generate capital. By creating fractional ownership, investors can expand their portfolio with verifiable and credible assets existing on the blockchain.

Forward-Looking Statements: This press release contains "forward-looking statements" within the meaning of the safe harbour provisions of the U.S. Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, including those with respect to the expected projects of BioTech Medics, Inc., and related companies. All statements that are included in this Press release, other than statements of historical fact, are forward-looking statements. Forward-looking statements involve known and unknown risks, assumptions, uncertainties, and other factors. Statements made in the future tense, and statements using-words-such as "may, "can," "could," "should," "predict," "aim'" "potential," "continue," "opportunity," "intend " "goal," "estimate," "expect," "expectations," "project," "projections," "plans," "anticipates," "believe," "think," "confident" "scheduled" or similar expressions are intended to identify forward-looking statements. Forward-looking statements are not a guarantee of performance and are subject to a number of risks and uncertainties, many of which are difficult to predict and are beyond our control.

These risks and uncertainties could cause actual results to differ materially from those expressed in or implied by the forward-looking statements, and therefore should be carefully considered. You should consider the areas of risk described in connection with any forward-looking statements that may be made herein. We caution you not to place undue reliance on the forward-looking statements, which speak only as of the date of this report and readers should carefully review this report in its entirety. We disclaim any obligation to update any of these forward-looking statements as a result of new information, future events, or otherwise, except as expressly required by law. Further information on our risk factors is contained in our filings with the OTC Markets and the SEC website. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

CONTACT INFORMATION

INVESTOR RELATIONS

STOCK SYMBOL: (BMCS-OTC)

EMAIL: biotecsmedics@gmail.com

WEBSITE: http://bmcs.company

WEBSITE: http://commodityvault.app

PHONE: 800.988.3782

LOCATION: WOODLAND HILLS, CA.

Contact Information

ANTHONY MILLER
PRES/CEO
tonymillertmiller@gmail.com
6615440275

Related Video

https://www.youtube.com/watch?v=I1-Ma5Qg0aY

SOURCE: BioTech Medics, Inc



View the original press release on accesswire.com

FAQ

When did BioTech Medics (BMCS) CEO participate in an interview with The Beast of Wall Street?

BioTech Medics (BMCS) CEO Anthony K. Miller participated in an interview with The Beast of Wall Street on August 8, 2024.

What new communication channel has BioTech Medics (BMCS) launched?

BioTech Medics (BMCS) has launched its official YouTube channel @Biotech Medics to share company-related content and improve investor communication.

What type of content will be available on BioTech Medics' (BMCS) YouTube channel?

BioTech Medics' (BMCS) YouTube channel will feature promotional videos, excerpts from the CEO's interview, and ongoing content related to the company's business and operations.

How does BioTech Medics (BMCS) CEO describe the company's business model?

BioTech Medics (BMCS) CEO Anthony K. Miller describes the company's business model as an excellent opportunity that he believes will be a long-running and profitable enterprise.

BIOTECH MEDICS INC

OTC:BMCS

BMCS Rankings

BMCS Latest News

BMCS Stock Data

3.90M
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Southlake